Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levobupivacaine Volume for Superior Trunk Block in Shoulder Surgery
NCT04941664Recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jan 2023
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of levobupivacaine in rotator cuff tear, sponsored by The Chinese University of Hong Kong. Primary endpoints: Changes of sensory & motor blockade (Readiness for surgery) of the upper extremity and Minimum effective volume (ml) of local anesthetic agent. Started Jan 2023; status: recruiting.
02
Drugs
levobupivacaine
03
Conditions
rotator cuff tear
Beyond the preview
Go deeper on NCT04941664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04941664.